Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Appili Therapeutics Inc (APLIF)

Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Appili Therapeutics Inc 21-1344 SUMMER ST. HALIFAX A5 B3H 0A8 CAN

www.appilitherapeutics.com P: 902-442-4655

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Appili Therapeutics Inc. is a biopharmaceutical company. It acquires, develops and commercializes novel medicines for unmet needs in the infectious disease. The company's lead product consist ATI-2307, ATI-1501 and ATI-1701 which are in clinical stage. Appili Therapeutics Inc. is based in Halifax, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,668
Enterprise Value, $K 9,628
Shares Outstanding, K 132,366
Float, K 116,694
% Float 88.16%
Short Interest, K 5
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.62
% of Insider Shareholders 11.84%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 70 K
Annual Net Income, $ -1,890 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -680 K
EBIT, $ -4,370 K
EBITDA, $ -4,360 K

Growth:

1-Year Return -41.67%
3-Year Return -68.81%
5-Year Return -98.80%
5-Year Revenue Growth -53.33%
5-Year Earnings Growth 91.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 02/12/26
Next Earnings Date 06/24/26
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Qtr 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

APLIF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -190.26%
Profit Margin % -2,700.00%
Debt/Equity -0.76
Price/Sales 11.12
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.09
Interest Coverage -0.26
60-Month Beta -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.